Belgium· BE-AMP-SAM233642-00
Ketek 400 mg
A telithromycin product containing telithromycin, registered in Belgium by Aventis Pharma. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Telithromycin is registered in 3 of 19 countries.
Countries holding a registration under ATC J01FA15 (telithromycin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Telithromycin · ATC J01FA15
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Telithromycin
- Manufacturer
- Aventis Pharma
- Country
- Belgium (BE)
- ATC code
- J01FA15
- ATC class
- Telithromycin
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb1690056
- be_apb0770818
- be_apb1690064
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
445 interactions on record for telithromycin.
Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Telithromycin · interactions on record
445 records
- 155 severe
- 218 moderate
- 8 minor
- 64 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Telithromycin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4476a3b4-5621-48ac-b095-aa014817b7e6 GET /v1/drugs/4476a3b4-5621-48ac-b095-aa014817b7e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ketek 400 mg",
"name_fr": "Ketek 400 mg",
"name_nl": "Ketek 400 mg",
"amp_code": "SAM233642-00",
"strengths": [
"400.0000"
],
"pack_count": 5,
"substances": [
"Telithromycin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Telithromycin",
"authorisation_numbers": [
"EU/1/01/191/001",
"EU/1/01/191/002",
"EU/1/01/191/003",
"EU/1/01/191/004",
"EU/1/01/191/006"
]
}See everything about telithromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.